Healthcare Data Interoperability Market Scope and Size by 2031
[Research Report] Healthcare data interoperability market size is projected to grow from US$ 4.312 billion in 2022 to US$ 15.90 billion by 2031; it is estimated to record a CAGR of 16.2% during 2022–2031.
Market Insights and Analyst View:
In healthcare data interoperability, electronic health records and other health information are exchanged between a variety of parties involved, including healthcare facilities and insurance companies. In order for healthcare systems and their infrastructure to function efficiently, healthcare interoperability is essential for information to be shared, accessed and coordinated seamlessly. Due to its highly personalized integration, delivery of personalized care, and scaling of healthcare interoperability systems, the healthcare interoperability market is extremely challenging.
The healthcare data interoperability market is majorly driven by factors such as patient-centric care delivery programs and rising concerns over increasing healthcare costs. Companies are constantly involved in selling their innovative products through off-the-shelf and e-commerce platforms, which have paved the way for significant growth opportunities for the players operating in the healthcare interoperability market.
Growth Drivers:
Several factors will drive the growth of the healthcare interoperability market, including the growing adoption and investment of digital healthcare solutions by healthcare providers worldwide and the rising healthcare costs. Due to the fact that healthcare interoperability solutions can reduce healthcare costs, they are expected to be adopted more widely over the forecast period and the market will grow. The adoption of healthcare interoperability solutions can improve healthcare efficiency, improve patient care, reduce healthcare costs, and reduce physician burnout, among other benefits. As a result, the healthcare interoperability market is projected to grow over the forecast period as healthcare IT and interoperability solutions continue to invest in healthcare IT and interoperability solutions. A total of US$ 2.7 million was awarded to four organizations in September 2021 under the Leading Edge Acceleration Projects in Health Information Technology program by the Office of the National Coordinator for Health Information Technology for exploring new opportunities for the adoption and use of health IT standards across the healthcare ecosystem as part of the Leading Edge Acceleration Projects in Health Information Technology program.
A major concern of governments is the increasing healthcare expenditure around the world, and in order to reduce that expenditure, healthcare IT solutions are being adopted and deployed. As a result, healthcare interoperability solutions are expected to be increasingly adopted, as they play a crucial role in transferring data. According to the Federal Statistical Office (Destatis) of Germany, healthcare expenditures in Germany are rising year over year, reaching US$ 468 billion (EUR 441 billion) in 2021, according to its June 2022 report. The healthcare interoperability market will also grow as a result of the launch of new products by market players in the area. For instance, CareCloud Inc. released CareCloud Connector in December 2019, a next-generation interface and data management engine for healthcare organizations. Data management and deployment speed are enhanced while interface control and visibility are improved as the solution provides ready-to-use integration. Based on the above-mentioned factors, the healthcare data interoperability market is expected to grow during the forecast period.
Strategic Insights
Report Segmentation and Scope:
The “Global Healthcare Data Interoperability Market” is segmented based on deployment, type, level, end user, and geography. The healthcare data interoperability market is bifurcated based on deployment into cloud-based and on-premise. Based on type, the healthcare data interoperability market is categorized into solutions and services. Based on level, the healthcare data interoperability market is segmented into foundational, structural, and semantic. Based on end user, the healthcare interoperability market is segmented into healthcare providers, healthcare payers, and pharmacies. The healthcare data interoperability market, based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
The healthcare data interoperability market, by type, is segmented into solutions and services. The service segment held the largest share of the market in 2022. As a result of the presence of a substantial number of interoperability solutions providers, the service segment is expected to account for most of the market. The segment is also growing as healthcare and scientific communities become increasingly interested in cloud computing and cloud-based platforms as a means to minimize their overall operational costs for better and faster performance of healthcare applications.
The healthcare data interoperability market is segmented based on level into foundational, structural, and semantic. The structural segment held the largest market share in 2022. The segment's growth is due to the ability of the recipient system to interpret information at the field level. This specifies the format for sending messages from one system to another. This is essential for users to comprehend the purpose of the information clearly.
Based on deployment, the healthcare data interoperability market is segmented into cloud-based and on-premise. The cloud-based segment held the largest market share in 2022. A cloud-based electronic health record (EHR) offers independent physicians security as well as cost savings compared to server-based EHRs. The EHRs in the cloud are shifted to the software as a service (SAAS) provider, including maintenance and updates, so the practice has fewer resources to devote to the system and more time to patients.
Based on end user, the healthcare interoperability market is segmented into healthcare providers, healthcare payers, and pharmacies. The healthcare providers held the largest market share in 2022. Healthcare interoperability enables seamless coordination among healthcare providers within a patient's circle of care, increasing the likelihood of accurate diagnosis, timely treatment, and better outcomes. By knowing their health history, patients can be more active in their treatment. Healthcare providers can increase the speed and efficiency of care delivery by enhancing interoperability by providing seamless access to patient health information, reducing duplication of testing, and minimizing medical errors.
Regional Analysis:
Based on geography, the healthcare data interoperability market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America is likely to acquire a significant share of the global market in 2022. The North American region is expected to hold a significant share of the healthcare data interoperability market due to the increasing investment in digitalizing the healthcare infrastructure, the increase in healthcare expenditure, and the launch of new products. According to the Canadian Institute for Health Information, in 2021, Canadian healthcare infrastructure increased from US$ 267 billion in 2021 to US$ 308 billion in 2021. Further, in the North American region, the United States is expected to be one of the largest markets for healthcare interoperability solutions since it is a major country where digital healthcare solutions like electronic health records (EHRs) are widely used in almost every hospital. In a study published in December 2019 entitled “Assessment of Electronic Health Record Use Between US and Non-US Health Systems”, clinicians in the US were more likely to use the EHR actively for clinical tasks, resulting in the adoption of healthcare interoperability solutions.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global healthcare data interoperability market are listed below:
- In April 2022, Embratel launched the Embratel Saúde Interoperabilidade solution, suitable for public and private institutions that seek to solve the challenges of clinical connectivity, information integration, and sharing of medical records for an integral view of healthcare.
- In March 2022, eHealth Exchange, a non-profit health information network connecting providers and federal agencies, received a new Innovation Grant program of US$ 550,000 to help accelerate electronic health information exchange or develop new technological connectivity tools.
- In January 2022, The Biden administration released a governance framework for nationwide health information exchange to facilitate secure nationwide information sharing among disparate healthcare entities, this framework will establish legal and technical baseline requirements.
Competitive Landscape and Key Companies:
Koninklijke Philips NV, Oracle Corporation (Cerner Corporation), EPIC Systems Corporation, NextGen Healthcare Inc., Koch Software Investments (Infor Inc.), Jitterbit, Virtusa Corpopration, Orion Health Group Limited, International Business Machines Corporation (IBM), and Infor Inc are the major healthcare data interoperability market companies. These companies focus on various growth strategies such as new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Healthcare Interoperability Solution Market - By Type
1.3.2 Healthcare Interoperability Solution Market - By Interoperability Level
1.3.3 Healthcare Interoperability Solution Market - By Mode of Deployment
1.3.4 Healthcare Interoperability Solution Market - By Application
1.3.5 Healthcare Interoperability Solution Market - By End User
1.3.6 Healthcare Interoperability Solution Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEALTHCARE INTEROPERABILITY SOLUTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - GLOBAL MARKET ANALYSIS
6.1. HEALTHCARE INTEROPERABILITY SOLUTION - GLOBAL MARKET OVERVIEW
6.2. HEALTHCARE INTEROPERABILITY SOLUTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SOFTWARE SOLUTIONS
7.3.1. Overview
7.3.2. Software Solutions Market Forecast and Analysis
7.3.3. EHR Interoperability Solutions Market
7.3.3.1. Overview
7.3.3.2. EHR Interoperability Solutions Market Forecast and Analysis
7.3.4. Lab System Interoperability Solutions Market
7.3.4.1. Overview
7.3.4.2. Lab System Interoperability Solutions Market Forecast and Analysis
7.3.5. Imaging System Interoperability Solutions Market
7.3.5.1. Overview
7.3.5.2. Imaging System Interoperability Solutions Market Forecast and Analysis
7.3.6. Healthcare Information Exchange Interoperability Solutions Market
7.3.6.1. Overview
7.3.6.2. Healthcare Information Exchange Interoperability Solutions Market Forecast and Analysis
7.3.7. Enterprise Interoperability Solutions Market
7.3.7.1. Overview
7.3.7.2. Enterprise Interoperability Solutions Market Forecast and Analysis
7.3.8. Other Interoperability Solutions Market
7.3.8.1. Overview
7.3.8.2. Other Interoperability Solutions Market Forecast and Analysis
7.4. SERVICES
7.4.1. Overview
7.4.2. Services Market Forecast and Analysis
8. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - REVENUE AND FORECASTS TO 2028 - INTEROPERABILITY LEVEL
8.1. OVERVIEW
8.2. INTEROPERABILITY LEVEL MARKET FORECASTS AND ANALYSIS
8.3. FOUNDATIONAL INTEROPERABILITY
8.3.1. Overview
8.3.2. Foundational Interoperability Market Forecast and Analysis
8.4. STRUCTURAL INTEROPERABILITY
8.4.1. Overview
8.4.2. Structural Interoperability Market Forecast and Analysis
8.5. SEMANTIC INTEROPERABILITY
8.5.1. Overview
8.5.2. Semantic Interoperability Market Forecast and Analysis
9. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF DEPLOYMENT
9.1. OVERVIEW
9.2. MODE OF DEPLOYMENT MARKET FORECASTS AND ANALYSIS
9.3. CLOUD BASED
9.3.1. Overview
9.3.2. Cloud Based Market Forecast and Analysis
9.4. ON PREMISE
9.4.1. Overview
9.4.2. On Premise Market Forecast and Analysis
10. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. DIAGNOSIS
10.3.1. Overview
10.3.2. Diagnosis Market Forecast and Analysis
10.4. TREATMENT
10.4.1. Overview
10.4.2. Treatment Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. HEALTHCARE INTEROPERABILITY SOLUTION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HEALTHCARE PROVIDERS
11.3.1. Overview
11.3.2. Healthcare Providers Market Forecast and Analysis
11.3.3. Hospitals and Clinics Market
11.3.3.1. Overview
11.3.3.2. Hospitals and Clinics Market Forecast and Analysis
11.3.4. Long-Term Care Centers Market
11.3.4.1. Overview
11.3.4.2. Long-Term Care Centers Market Forecast and Analysis
11.3.5. Diagnostic and Imaging Centers Market
11.3.5.1. Overview
11.3.5.2. Diagnostic and Imaging Centers Market Forecast and Analysis
11.3.6. Other Providers Market
11.3.6.1. Overview
11.3.6.2. Other Providers Market Forecast and Analysis
11.4. HEALTHCARE PAYERS
11.4.1. Overview
11.4.2. Healthcare Payers Market Forecast and Analysis
11.5. PHARMACIES
11.5.1. Overview
11.5.2. Pharmacies Market Forecast and Analysis
12. HEALTHCARE INTEROPERABILITY SOLUTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Healthcare Interoperability Solution Market Overview
12.1.2 North America Healthcare Interoperability Solution Market Forecasts and Analysis
12.1.3 North America Healthcare Interoperability Solution Market Forecasts and Analysis - By Type
12.1.4 North America Healthcare Interoperability Solution Market Forecasts and Analysis - By Interoperability Level
12.1.5 North America Healthcare Interoperability Solution Market Forecasts and Analysis - By Mode of Deployment
12.1.6 North America Healthcare Interoperability Solution Market Forecasts and Analysis - By Application
12.1.7 North America Healthcare Interoperability Solution Market Forecasts and Analysis - By End User
12.1.8 North America Healthcare Interoperability Solution Market Forecasts and Analysis - By Countries
12.1.8.1 United States Healthcare Interoperability Solution Market
12.1.8.1.1 United States Healthcare Interoperability Solution Market by Type
12.1.8.1.2 United States Healthcare Interoperability Solution Market by Interoperability Level
12.1.8.1.3 United States Healthcare Interoperability Solution Market by Mode of Deployment
12.1.8.1.4 United States Healthcare Interoperability Solution Market by Application
12.1.8.1.5 United States Healthcare Interoperability Solution Market by End User
12.1.8.2 Canada Healthcare Interoperability Solution Market
12.1.8.2.1 Canada Healthcare Interoperability Solution Market by Type
12.1.8.2.2 Canada Healthcare Interoperability Solution Market by Interoperability Level
12.1.8.2.3 Canada Healthcare Interoperability Solution Market by Mode of Deployment
12.1.8.2.4 Canada Healthcare Interoperability Solution Market by Application
12.1.8.2.5 Canada Healthcare Interoperability Solution Market by End User
12.1.8.3 Mexico Healthcare Interoperability Solution Market
12.1.8.3.1 Mexico Healthcare Interoperability Solution Market by Type
12.1.8.3.2 Mexico Healthcare Interoperability Solution Market by Interoperability Level
12.1.8.3.3 Mexico Healthcare Interoperability Solution Market by Mode of Deployment
12.1.8.3.4 Mexico Healthcare Interoperability Solution Market by Application
12.1.8.3.5 Mexico Healthcare Interoperability Solution Market by End User
12.2. EUROPE
12.2.1 Europe Healthcare Interoperability Solution Market Overview
12.2.2 Europe Healthcare Interoperability Solution Market Forecasts and Analysis
12.2.3 Europe Healthcare Interoperability Solution Market Forecasts and Analysis - By Type
12.2.4 Europe Healthcare Interoperability Solution Market Forecasts and Analysis - By Interoperability Level
12.2.5 Europe Healthcare Interoperability Solution Market Forecasts and Analysis - By Mode of Deployment
12.2.6 Europe Healthcare Interoperability Solution Market Forecasts and Analysis - By Application
12.2.7 Europe Healthcare Interoperability Solution Market Forecasts and Analysis - By End User
12.2.8 Europe Healthcare Interoperability Solution Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Healthcare Interoperability Solution Market
12.2.8.1.1 Germany Healthcare Interoperability Solution Market by Type
12.2.8.1.2 Germany Healthcare Interoperability Solution Market by Interoperability Level
12.2.8.1.3 Germany Healthcare Interoperability Solution Market by Mode of Deployment
12.2.8.1.4 Germany Healthcare Interoperability Solution Market by Application
12.2.8.1.5 Germany Healthcare Interoperability Solution Market by End User
12.2.8.2 France Healthcare Interoperability Solution Market
12.2.8.2.1 France Healthcare Interoperability Solution Market by Type
12.2.8.2.2 France Healthcare Interoperability Solution Market by Interoperability Level
12.2.8.2.3 France Healthcare Interoperability Solution Market by Mode of Deployment
12.2.8.2.4 France Healthcare Interoperability Solution Market by Application
12.2.8.2.5 France Healthcare Interoperability Solution Market by End User
12.2.8.3 Italy Healthcare Interoperability Solution Market
12.2.8.3.1 Italy Healthcare Interoperability Solution Market by Type
12.2.8.3.2 Italy Healthcare Interoperability Solution Market by Interoperability Level
12.2.8.3.3 Italy Healthcare Interoperability Solution Market by Mode of Deployment
12.2.8.3.4 Italy Healthcare Interoperability Solution Market by Application
12.2.8.3.5 Italy Healthcare Interoperability Solution Market by End User
12.2.8.4 Spain Healthcare Interoperability Solution Market
12.2.8.4.1 Spain Healthcare Interoperability Solution Market by Type
12.2.8.4.2 Spain Healthcare Interoperability Solution Market by Interoperability Level
12.2.8.4.3 Spain Healthcare Interoperability Solution Market by Mode of Deployment
12.2.8.4.4 Spain Healthcare Interoperability Solution Market by Application
12.2.8.4.5 Spain Healthcare Interoperability Solution Market by End User
12.2.8.5 United Kingdom Healthcare Interoperability Solution Market
12.2.8.5.1 United Kingdom Healthcare Interoperability Solution Market by Type
12.2.8.5.2 United Kingdom Healthcare Interoperability Solution Market by Interoperability Level
12.2.8.5.3 United Kingdom Healthcare Interoperability Solution Market by Mode of Deployment
12.2.8.5.4 United Kingdom Healthcare Interoperability Solution Market by Application
12.2.8.5.5 United Kingdom Healthcare Interoperability Solution Market by End User
12.2.8.6 Rest of Europe Healthcare Interoperability Solution Market
12.2.8.6.1 Rest of Europe Healthcare Interoperability Solution Market by Type
12.2.8.6.2 Rest of Europe Healthcare Interoperability Solution Market by Interoperability Level
12.2.8.6.3 Rest of Europe Healthcare Interoperability Solution Market by Mode of Deployment
12.2.8.6.4 Rest of Europe Healthcare Interoperability Solution Market by Application
12.2.8.6.5 Rest of Europe Healthcare Interoperability Solution Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Healthcare Interoperability Solution Market Overview
12.3.2 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis
12.3.3 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis - By Interoperability Level
12.3.5 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis - By Mode of Deployment
12.3.6 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis - By Application
12.3.7 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Healthcare Interoperability Solution Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Healthcare Interoperability Solution Market
12.3.8.1.1 Australia Healthcare Interoperability Solution Market by Type
12.3.8.1.2 Australia Healthcare Interoperability Solution Market by Interoperability Level
12.3.8.1.3 Australia Healthcare Interoperability Solution Market by Mode of Deployment
12.3.8.1.4 Australia Healthcare Interoperability Solution Market by Application
12.3.8.1.5 Australia Healthcare Interoperability Solution Market by End User
12.3.8.2 China Healthcare Interoperability Solution Market
12.3.8.2.1 China Healthcare Interoperability Solution Market by Type
12.3.8.2.2 China Healthcare Interoperability Solution Market by Interoperability Level
12.3.8.2.3 China Healthcare Interoperability Solution Market by Mode of Deployment
12.3.8.2.4 China Healthcare Interoperability Solution Market by Application
12.3.8.2.5 China Healthcare Interoperability Solution Market by End User
12.3.8.3 India Healthcare Interoperability Solution Market
12.3.8.3.1 India Healthcare Interoperability Solution Market by Type
12.3.8.3.2 India Healthcare Interoperability Solution Market by Interoperability Level
12.3.8.3.3 India Healthcare Interoperability Solution Market by Mode of Deployment
12.3.8.3.4 India Healthcare Interoperability Solution Market by Application
12.3.8.3.5 India Healthcare Interoperability Solution Market by End User
12.3.8.4 Japan Healthcare Interoperability Solution Market
12.3.8.4.1 Japan Healthcare Interoperability Solution Market by Type
12.3.8.4.2 Japan Healthcare Interoperability Solution Market by Interoperability Level
12.3.8.4.3 Japan Healthcare Interoperability Solution Market by Mode of Deployment
12.3.8.4.4 Japan Healthcare Interoperability Solution Market by Application
12.3.8.4.5 Japan Healthcare Interoperability Solution Market by End User
12.3.8.5 South Korea Healthcare Interoperability Solution Market
12.3.8.5.1 South Korea Healthcare Interoperability Solution Market by Type
12.3.8.5.2 South Korea Healthcare Interoperability Solution Market by Interoperability Level
12.3.8.5.3 South Korea Healthcare Interoperability Solution Market by Mode of Deployment
12.3.8.5.4 South Korea Healthcare Interoperability Solution Market by Application
12.3.8.5.5 South Korea Healthcare Interoperability Solution Market by End User
12.3.8.6 Rest of Asia-Pacific Healthcare Interoperability Solution Market
12.3.8.6.1 Rest of Asia-Pacific Healthcare Interoperability Solution Market by Type
12.3.8.6.2 Rest of Asia-Pacific Healthcare Interoperability Solution Market by Interoperability Level
12.3.8.6.3 Rest of Asia-Pacific Healthcare Interoperability Solution Market by Mode of Deployment
12.3.8.6.4 Rest of Asia-Pacific Healthcare Interoperability Solution Market by Application
12.3.8.6.5 Rest of Asia-Pacific Healthcare Interoperability Solution Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Healthcare Interoperability Solution Market Overview
12.4.2 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis
12.4.3 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis - By Interoperability Level
12.4.5 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis - By Mode of Deployment
12.4.6 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis - By Application
12.4.7 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Healthcare Interoperability Solution Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Healthcare Interoperability Solution Market
12.4.8.1.1 South Africa Healthcare Interoperability Solution Market by Type
12.4.8.1.2 South Africa Healthcare Interoperability Solution Market by Interoperability Level
12.4.8.1.3 South Africa Healthcare Interoperability Solution Market by Mode of Deployment
12.4.8.1.4 South Africa Healthcare Interoperability Solution Market by Application
12.4.8.1.5 South Africa Healthcare Interoperability Solution Market by End User
12.4.8.2 Saudi Arabia Healthcare Interoperability Solution Market
12.4.8.2.1 Saudi Arabia Healthcare Interoperability Solution Market by Type
12.4.8.2.2 Saudi Arabia Healthcare Interoperability Solution Market by Interoperability Level
12.4.8.2.3 Saudi Arabia Healthcare Interoperability Solution Market by Mode of Deployment
12.4.8.2.4 Saudi Arabia Healthcare Interoperability Solution Market by Application
12.4.8.2.5 Saudi Arabia Healthcare Interoperability Solution Market by End User
12.4.8.3 U.A.E Healthcare Interoperability Solution Market
12.4.8.3.1 U.A.E Healthcare Interoperability Solution Market by Type
12.4.8.3.2 U.A.E Healthcare Interoperability Solution Market by Interoperability Level
12.4.8.3.3 U.A.E Healthcare Interoperability Solution Market by Mode of Deployment
12.4.8.3.4 U.A.E Healthcare Interoperability Solution Market by Application
12.4.8.3.5 U.A.E Healthcare Interoperability Solution Market by End User
12.4.8.4 Rest of Middle East and Africa Healthcare Interoperability Solution Market
12.4.8.4.1 Rest of Middle East and Africa Healthcare Interoperability Solution Market by Type
12.4.8.4.2 Rest of Middle East and Africa Healthcare Interoperability Solution Market by Interoperability Level
12.4.8.4.3 Rest of Middle East and Africa Healthcare Interoperability Solution Market by Mode of Deployment
12.4.8.4.4 Rest of Middle East and Africa Healthcare Interoperability Solution Market by Application
12.4.8.4.5 Rest of Middle East and Africa Healthcare Interoperability Solution Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Healthcare Interoperability Solution Market Overview
12.5.2 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis
12.5.3 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis - By Type
12.5.4 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis - By Interoperability Level
12.5.5 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis - By Mode of Deployment
12.5.6 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis - By Application
12.5.7 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis - By End User
12.5.8 South and Central America Healthcare Interoperability Solution Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Healthcare Interoperability Solution Market
12.5.8.1.1 Brazil Healthcare Interoperability Solution Market by Type
12.5.8.1.2 Brazil Healthcare Interoperability Solution Market by Interoperability Level
12.5.8.1.3 Brazil Healthcare Interoperability Solution Market by Mode of Deployment
12.5.8.1.4 Brazil Healthcare Interoperability Solution Market by Application
12.5.8.1.5 Brazil Healthcare Interoperability Solution Market by End User
12.5.8.2 Argentina Healthcare Interoperability Solution Market
12.5.8.2.1 Argentina Healthcare Interoperability Solution Market by Type
12.5.8.2.2 Argentina Healthcare Interoperability Solution Market by Interoperability Level
12.5.8.2.3 Argent
The List of Companies
1. Allscripts Healthcare Solutions, Inc.
2. Cerner Corporation
3. Intersystems Corporation
4. Orion Health Group Limited
5. Koninklijke Philips N.V.
6. Visolve Inc.
7. Infor, Inc.
8. Nextgen Healthcare, Inc.
9. EPIC Systems Corporation
10. iNTERFACEWARE
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For